Trending Stories
From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.
ScImage Receives Enabling Technology Leadership Award
Partner News | Published: Friday, February 26, 2021
ScImage, Inc., a leading provider of Enterprise Imaging solutions, announces it has received Frost & Sullivan’s 2020 North America Enabling Technology Leadership Award for its Cloud-based Enterprise Imaging Solutions.
Genetesis Applauds CMS’s MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices
Partner News | Published: Wednesday, January 13, 2021
The Centers for Medicare & Medicaid Services (CMS) announced the establishment of the Medicare Coverage of Innovative Technology (MCIT) pathway, to bring new and innovative technologies to beneficiariesScImage Founder/CEO Reflects on 2020
Partner News | Published: Tuesday, January 12, 2021
ScImage, Inc., a leading provider of Enterprise Imaging solutions, announces significant expansion of deploying end-to-end diagnostic imaging workflows entirely in the Cloud for Cardiology, Vascular,CardioFlux Magnetocardiograph Case Studies
Partner News | Published: Wednesday, January 6, 2021
Magnetocardiography (MCG) has been assessed over the last 30 years as a rapid diagnostic tool for various forms of cardiac pathophysiology. MCG is able to detect and discern miniscule differences in the magnetic fields generated by the heart’s natural pacemaker activity. These fields have previously been shown to change with cardiac ischemia due to dysfunction of the ion channels responsible for repolarization and depolarization of the myocardium.
4 things to consider as you implement your Cardiovascular outmigration strategy
Partner News | Published: Wednesday, December 16, 2020
By Marc Toth, Vice President of Cardiovascular Services, Atlas Healthcare Partners and Meredith Banasiak, EDAC, Director of Research, Boulder Associates, Inc. It is anticipated that by 2030, 82% of allFDA Awards Genetesis Breakthrough Device Designation for CardioFlux® Imaging Technology
Partner News | Published: Tuesday, December 15, 2020
Genetesis, Inc., a MedAxiom partner, announced today that its flagship product, CardioFlux®, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for theJim Andrews Appointed to Biome Analytics Board
Partner News | Published: Tuesday, December 8, 2020
Biome Analytics, the leading cardiovascular performance company announced that they have expanded the Board of Directors with the appointment of Jim Andrews. Andrews is currently senior vice president,From Sleep Apnea Diagnosis to Treatment in Less Than Two Weeks on Average
Partner News | Published: Monday, December 7, 2020
The link between moderate-to-severe sleep apnea (SA) and serious cardiovascular disease (CVD) has been broadly accepted. Undiagnosed sleep apnea is a major comorbidity of CVD and a significant risk factor for atrial fibrillation, stroke, congestive heart failure, and hypertension.
Varsity Healthcare Partners Completes Growth Capital Investment with Partners First Cardiology
Partner News | Published: Monday, November 30, 2020
Varsity Healthcare Partners (“VHP”), a leading healthcare services private equity investment firm, announced a growth equity investment with Partners First Cardiology (“Partners First”, “PFC”, or “the Company”).
MedAxiom Announces Industry Partnership with Partners First Cardiology
Partner News | Published: Thursday, November 19, 2020
Partners First Cardiology, a physician practice Management Services Organization (MSO) that has a practice management solution designed exclusively for cardiologists.